Filtered By:
Therapy: Chemotherapy

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 472 results found since Jan 2013.

Eugenol: A New Option in Combination Therapy with Sorafenib for the Treatment of Undifferentiated Thyroid Cancer
This study investigated whether eugenol in combination with sorafenib was more effective than either substance individually in triggering apoptosis in the UTC. The IC50 of sorafenib and eugenol was determined in a UTC cell line (8305C) by MTT assay, and their synergistic effect in combination therapy was investigated. Flow cytometry was used to evaluate the rate of apoptosis in treated cells. To confirm that cell death occurred through apoptosis, immunoblotting was used to determine the relative cleavage of caspase-8 and caspase-9. The IC50 of sorafenib was 20 µM, and that of eugenol was 2100 µM. The sorafenib-eugenol co...
Source: Iranian Journal of Allergy, Asthma and Immunology - July 13, 2022 Category: Allergy & Immunology Authors: Pedram Talezadeh Shirazi Shirin Farjadian Mohammad Hossein Dabbaghmanesh Hossein Jonaidi Ali Alavianmehr Mehdi Kalani Ladan Emadi Source Type: research

Drug allergy desensitization is not a unique recipe
Purpose of review Drug desensitization is the only therapeutic option for patients with drug allergies who need to receive the drugs they are allergic to, and it is especially critical in patients with an urgent need for chemotherapy, biologics, or antibiotics, where equally effective alternatives might not be available. However, drug desensitization is not a cookbook where anyone with no experience or specific training can find a general recipe. This review article will approach the singularities that make personalized and highly specialized care essential in this field. Recent findings Drug desensitization nee...
Source: Current Opinion in Allergy and Clinical Immunology - June 1, 2022 Category: Allergy & Immunology Tags: PERSONALIZED MEDICINE: Edited by Henry Milgrom and René Maximiliano Gómez Source Type: research

Anaphylactic reaction to carboplatin diagnosed by skin testing —a reliable tool in platinum-based immediate-type hypersensitivity reactions
SummaryImmediate-type hypersensitivity reactions (IHRs) to carboplatin (CA) are most commonly reported in ovarian cancer patients. A  54-year-old woman with stage IV melanoma suffering from metastasis in the entire right lower extremity was presented to our allergy outpatient clinic for diagnostic work-up due to an anaphylactic reaction with palmoplantar erythema, conjunctivitis along with facial erythema, and an incipient decr ease in blood pressure during a chemotherapy regimen with dacarbazine and carboplatin upon re-administration. A subsequently carried out allergological work-up with skin testing (ST) revealed CA...
Source: Wiener Medizinische Wochenschrift - May 20, 2022 Category: General Medicine Source Type: research

Why Acupuncture Is Going Mainstream in Medicine
When the opioid addiction crisis began to surge in the U.S. about a decade ago, Dr. Medhat Mikhael spent a lot of time talking to his patients about other ways to heal pain besides opioids, from other types of medications to alternative treatments. As a pain management specialist at MemorialCare Orange Coast Medical Center in Fountain Valley, Calif., he didn’t anticipate leaving behind the short-term use of opioids altogether, since they work so well for post-surgical pain. But he wanted to recommend a remedy that was safer and still effective. That turned out to be acupuncture. “Like any treatment, acupuncture...
Source: TIME: Health - April 29, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized healthscienceclimate medicine Source Type: news

Think About Antibiotics Like We Think About Chemotherapy Think About Antibiotics Like We Think About Chemotherapy
Healthcare providers can be somewhat cavalier about ordering antibiotics. Maybe if we thought about antibiotics like we think about chemotherapy, we ' d do better with our prescribing practices.Medscape Blogs
Source: Medscape Allergy Headlines - April 27, 2022 Category: Allergy & Immunology Tags: Infectious Diseases Blog Source Type: news

Mesna, an unusual agent causing hypersensitivity reactions during chemotherapy
Ann Allergy Asthma Immunol. 2022 Apr 25:S1081-1206(22)00364-7. doi: 10.1016/j.anai.2022.04.023. Online ahead of print.NO ABSTRACTPMID:35476968 | DOI:10.1016/j.anai.2022.04.023
Source: Annals of Allergy, Asthma and Immunology - April 27, 2022 Category: Allergy & Immunology Authors: Elizabeth Mu ñoz-Osores Ang élica Wietstruck Rodrigo Hoyos-Bachiloglu Source Type: research

Analysis of the Treatment and Survival of Sinonasal Extramedullary Plasmacytoma
CONCLUSION: In patients with SN-EMP five-year overall survival was found to be 74.0% with decreased survival associated with a frontal sinus primary site and being aged 60 or older. Patients receiving no treatment, chemotherapy alone, or radiotherapy with chemotherapy was associated with lower survival. Receiving surgery plus radiotherapy was associated with the highest five-year overall survival.PMID:35440217 | DOI:10.1177/19458924221092529
Source: American Journal of Rhinology and Allergy - April 20, 2022 Category: ENT & OMF Authors: Jeff Gao Christopher C Tseng Gregory L Barinsky Christina H Fang Jordon G Grube Wayne D Hsueh Soly Baredes Jean Anderson Eloy Source Type: research